Genenta Science (GNTA) Short Interest Ratio & Short Volume $3.76 -0.06 (-1.44%) Closing price 08/4/2025 03:00 PM EasternExtended Trading$3.68 -0.08 (-2.12%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genenta Science Short Interest DataGenenta Science (GNTA) has a short interest of 6,600 shares. This marks a 69.23% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 6,291 shares to cover all short positions.Current Short Interest6,600 sharesPrevious Short Interest3,900 sharesChange Vs. Previous Month+69.23%Dollar Volume Sold Short$25.11 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares18,290,000 sharesPercentage of Shares Shorted0.04%Today's Trading Volume975 sharesAverage Trading Volume6,291 sharesToday's Volume Vs. Average15% Short Selling Genenta Science? Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNTA Short Interest Over TimeGNTA Days to Cover Over TimeGNTA Percentage of Float Shorted Over Time Genenta Science Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20256,600 shares $25.11 thousand +69.2%N/A0.5 $3.81 6/30/20253,900 shares $11.90 thousand +39.3%0.0%0.3 $3.05 6/15/20252,800 shares $10.85 thousand +40.0%0.0%0.5 $3.88 5/31/20252,000 shares $8.96 thousand -31.0%0.0%0.1 $4.48 5/15/20252,900 shares $12.21 thousand -17.1%0.0%0.2 $4.21 4/30/20253,500 shares $13.62 thousand +45.8%N/A0.2 $3.89 4/15/20252,400 shares $9.19 thousand +84.6%0.0%0.1 $3.83 3/31/20251,300 shares $5.06 thousand No Change0.0%0.1 $3.90 3/15/20251,300 shares $4.99 thousand -13.3%0.0%0.1 $3.84 2/28/20251,500 shares $5.85 thousand -40.0%0.0%0.1 $3.90 Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 2/15/20252,500 shares $10.93 thousand -26.5%0.0%0.2 $4.37 1/31/20253,400 shares $11.97 thousand +30.8%N/A0.3 $3.52 1/15/20252,600 shares $10.63 thousand +18.2%N/A0.2 $4.09 12/31/20242,200 shares $9.57 thousand -29.0%N/A0.1 $4.35 12/15/20243,100 shares $15.90 thousand +121.4%N/A0.2 $5.13 11/30/20241,400 shares $7.28 thousand -64.1%N/A0.1 $5.20 11/15/20243,900 shares $19.58 thousand -26.4%N/A0.3 $5.02 10/31/20245,300 shares $27.03 thousand -54.3%N/A0.4 $5.10 10/15/202411,600 shares $67.28 thousand +152.2%N/A0.9 $5.80 9/30/20244,600 shares $19.64 thousand -20.7%N/A0.3 $4.27 9/15/20245,800 shares $22.91 thousand -40.8%N/A0.5 $3.95 8/31/20249,800 shares $37.93 thousand -18.3%N/A0.8 $3.87 8/15/202412,000 shares $52.20 thousand -14.9%N/A1.1 $4.35 7/31/202414,100 shares $60.63 thousand +227.9%N/A1.2 $4.30 7/15/20244,300 shares $14.88 thousand +4.9%N/A0.3 $3.46 6/30/20244,100 shares $12.71 thousand -18.0%N/A1 $3.10 6/15/20245,000 shares $16.19 thousand +47.1%N/A1.2 $3.24 5/31/20243,400 shares $11.66 thousand +79.0%N/A0.6 $3.43 5/15/20241,900 shares $6.08 thousand -60.4%N/A0.3 $3.20 4/30/20244,800 shares $14.78 thousand +23.1%N/A0.8 $3.08 4/15/20243,900 shares $13.12 thousand +30.0%N/A0.7 $3.37 3/31/20243,000 shares $10.50 thousand -9.1%N/A0.7 $3.50 3/15/20243,300 shares $12.87 thousand -5.7%N/A0.8 $3.90 2/29/20243,500 shares $15.40 thousand -5.4%N/A1.2 $4.40 2/15/20243,700 shares $14.80 thousand +5.7%N/A1.3 $4.00 1/31/20243,500 shares $14.11 thousand -5.4%N/A1.3 $4.03 1/15/20243,700 shares $16.47 thousand No ChangeN/A1.8 $4.45 12/31/20233,700 shares $18.32 thousand -32.7%N/A1.7 $4.95 12/15/20235,500 shares $27.61 thousand +14.6%N/A2.5 $5.02 11/30/20234,800 shares $23.76 thousand -35.1%N/A2.4 $4.95Alex’s “Next Magnificent Seven” stocks (Ad)The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.Watch the “Next Magnificent Seven” presentation here 11/15/20237,400 shares $38.48 thousand +37.0%N/A3.9 $5.20 10/31/20235,400 shares $28.84 thousand -25.0%N/A3.2 $5.34 10/15/20237,200 shares $40.25 thousand +1.4%N/A3.8 $5.59 9/30/20237,100 shares $36.57 thousand +10.9%N/A4.4 $5.15 9/15/20236,400 shares $36.03 thousand -1.5%N/A3.6 $5.63 8/31/20236,500 shares $37.70 thousand -17.7%N/A3.2 $5.80 8/15/20237,900 shares $43.69 thousand +9.7%N/A3.4 $5.53 7/31/20237,200 shares $39.17 thousand +50.0%N/A3 $5.44 7/15/20234,800 shares $28.56 thousand -14.3%N/A2.2 $5.95 6/30/20235,600 shares $32.98 thousand +7.7%N/A2.7 $5.89 6/15/20235,200 shares $29.85 thousand +300.0%N/A2.4 $5.74 5/31/20231,300 shares $7.93 thousand -23.5%N/A0.5 $6.10 5/15/20231,700 shares $9.54 thousand +54.6%N/A0.7 $5.61 4/30/20231,100 shares $6.60 thousand +266.7%N/A0.4 $6.00 4/15/2023300 shares $1.89 thousand No ChangeN/A0.1 $6.30 3/31/2023300 shares $1.73 thousand -40.0%N/A0.1 $5.75 3/15/2023500 shares $3.35 thousand -66.7%N/A0.1 $6.70 2/28/20231,500 shares $9.75 thousand +114.3%N/A0.3 $6.50 2/15/2023700 shares $4.59 thousand -22.2%N/A0.2 $6.55 1/31/2023900 shares $5.53 thousand -50.0%N/A0.2 $6.14 1/15/20231,800 shares $11.61 thousand -30.8%N/A0.4 $6.45 12/30/20222,600 shares $14.30 thousand +116.7%N/A0.6 $5.50 12/15/20221,200 shares $6.78 thousand +140.0%N/A0.4 $5.65 11/30/2022500 shares $2.61 thousand -80.8%N/A0.2 $5.21 11/15/20222,600 shares $10.82 thousand +225.0%N/A1.2 $4.16 10/31/2022800 shares $3.52 thousand +33.3%N/A0.4 $4.40 10/15/2022600 shares $2.74 thousand -25.0%N/A0.3 $4.57 9/30/2022800 shares $3.98 thousand -11.1%N/A0.3 $4.98 9/15/2022900 shares $4.72 thousand +125.0%N/A0.3 $5.24 8/31/2022400 shares $2.37 thousand -71.4%N/A0.1 $5.92 8/15/20221,400 shares $8.88 thousand -12.5%N/A0.4 $6.34 7/31/20221,600 shares $10.51 thousand -46.7%N/A0.3 $6.57 7/15/20223,000 shares $20.22 thousand No ChangeN/A0.6 $6.74 GNTA Short Interest - Frequently Asked Questions What is Genenta Science's current short interest? Short interest is the volume of Genenta Science shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 6,600 shares of GNTA short. Learn More on Genenta Science's current short interest. Is Genenta Science's short interest increasing or decreasing? Genenta Science saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 6,600 shares, an increase of 69.2% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genenta Science's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genenta Science: Annexon, Inc. (9.53%), Lifecore Biomedical, Inc. (7.60%), Monopar Therapeutics Inc. (3.46%), Vor Biopharma Inc. (22.16%), Aurora Cannabis Inc. (11.00%), Cardiff Oncology, Inc. (28.41%), Editas Medicine, Inc. (10.18%), DBV Technologies S.A. (0.05%), Inozyme Pharma, Inc. (7.79%), Prima BioMed Ltd (2.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Genenta Science stock? Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genenta Science? A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further. How often is Genenta Science's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Annexon Short Squeeze Lifecore Biomedical Short Squeeze Monopar Therapeutics Short Squeeze Vor Biopharma Short Squeeze Aurora Cannabis Short Squeeze Cardiff Oncology Short Squeeze Editas Medicine Short Squeeze DBV Technologies Short Squeeze Inozyme Pharma Short Squeeze Prima BioMed Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNTA) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNTA Stock Alerts